Gemma E. Hartley
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
-
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immunodeficiency and Autoimmune Disorders
Papers in
-
- SARS-CoV-2 and COVID-19 Research 5
- COVID-19 Clinical Research Studies 1
- SARS-CoV-2 detection and testing 1
-
- Immunotherapy and Immune Responses 2
- T-cell and B-cell Immunology 1
- Co-authors
- Robyn E. O’Hehir (6 shared papers)Emily S.J. Edwards (6 shared papers)Menno C. van Zelm (6 shared papers)P. Mark Hogarth (4 shared papers)Heidi E. Drummer (3 shared papers)Irene Boo (3 shared papers)Nirupama Varese (2 shared papers)James McMahon (1 shared paper)
- Journals
- Biochemical Society Transactions (1 paper)Science Immunology (1 paper)Clinical & Translational Immunology (1 paper)Journal of Clinical Immunology (1 paper)npj Vaccines (1 paper)
- Partner nations
- AustraliaUnited StatesNetherlands
In The Last Decade
Gemma E. Hartley
6 papers receiving 230 citations
Peers
Comparison fields: 5 of 38
- Infectious Diseases 186
- Immunology 76
- Modeling and Simulation 16
- Neurology 38
- Animal Science and Zoology 13
Countries citing papers authored by Gemma E. Hartley
This map shows the geographic impact of Gemma E. Hartley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gemma E. Hartley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gemma E. Hartley more than expected).
Fields of papers citing papers by Gemma E. Hartley
This network shows the impact of papers produced by Gemma E. Hartley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gemma E. Hartley. The network helps show where Gemma E. Hartley may publish in the future.
Co-authors
The 19 scholars most cited alongside Gemma E. Hartley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 182 | |
| 2 | 2020 | 13 | |
| 3 | 2023 | 11 | |
| 4 | 2022 | 11 | |
| 5 | 2022 | 10 | |
| 6 | 2024 | 8 |
About Gemma E. Hartley
Gemma E. Hartley is a scholar working on Infectious Diseases, Immunology, Oncology, Health and Organic Chemistry, having authored 6 papers that have together received 235 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (5 papers), Immunotherapy and Immune Responses (2 papers), CAR-T cell therapy research (2 papers), COVID-19 Clinical Research Studies (1 paper), Vaccine Coverage and Hesitancy (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), SARS-CoV-2 detection and testing (1 paper) and T-cell and B-cell Immunology (1 paper). The work is most often cited by research in Infectious Diseases (186 citations), Immunology (76 citations), Modeling and Simulation (16 citations), Neurology (38 citations) and Animal Science and Zoology (13 citations). Gemma E. Hartley has collaborated with scholars based in Australia, United States and Netherlands. Frequent co-authors include Robyn E. O’Hehir, Emily S.J. Edwards, Menno C. van Zelm, P. Mark Hogarth, Heidi E. Drummer, Irene Boo, Nirupama Varese, James McMahon, Pei M. Aui and Anton Y. Peleg. Their work appears in journals such as Biochemical Society Transactions, Science Immunology, Clinical & Translational Immunology, Journal of Clinical Immunology and npj Vaccines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.